Log in

Relevant bibliographies by topics / HIV treatment adherence / Books

To see the other types of publications on this topic, follow the link: HIV treatment adherence.

Books on the topic 'HIV treatment adherence'

Author: Grafiati

Published: 4 June 2021

Last updated: 4 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 30 books for your research on the topic 'HIV treatment adherence.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Gupta, Indrani. Determinants of adherence in the antiretroviral treatment programme of the government of India. Institute of Economic Growth, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Ka'opna, Lana Sue, and Nathan L. Linsk, eds. HIV Treatment Adherence. Routledge, 2013. http://dx.doi.org/10.4324/9780203052075.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Sue, Ka'opua Lana, and Linsk Nathan L, eds. HIV treatment adherence: Challenges for social services. Haworth Press, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Linsk, Nathan L., and Lana Sue Ka'opna. HIV Treatment Adherence: Challenges for Social Services. Taylor & Francis Group, 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Lana Sue, Ph.D. Ka'opua (Editor) and Nathan L. Linsk (Editor), eds. HIV Treatment Adherence: Challenging for Social Services (Journal of HIV/AIDS & Social Services) (Journal of HIV/AIDS & Social Services). Haworth Press, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Weiss, Jeffrey J., and Michael J. Stirratt. Psychiatric Aspects of Care Engagement and Medication Adherence in Antiretroviral-Based HIV Treatment and Prevention. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0029.

Full text

Abstract:

Care engagement and treatment adherence are directly related to HIV treatment outcomes and to mortality. Active drug use and psychiatric illness such as depressive and addictive disorders are significant barriers to care engagement and treatment adherence among persons living with HIV and those at high risk for HIV infection and eligible for pre-exposure prophylaxis (PrEP). This chapter addresses (1) psychiatric aspects of PrEP for HIV prevention, (2) the care continuum for individuals living with HIV infection, (3) psychiatric determinants of HIV care engagement, (4) behavioral interventions

APA, Harvard, Vancouver, ISO, and other styles

7

Cozza, Kelly L., Gary H. Wynn, Glenn W. Wortmann, Scott G. Williams, and Rita Rein. Psychopharmacological Treatment Issues in HIV/AIDS Psychiatry. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0042.

Full text

Abstract:

Attention to pharmacokinetics and pharmacodynamics and an understanding of intended effects, side effects, toxicities, and drug interactions are imperative when treating persons with HIV/AIDS. This chapter includes an essential review of drug interaction principles and an overview of current antiretroviral treatment (ART) and known side effects, toxicities, and drug interactions, in text and table format. The chapter concludes with a presentation of psychotropic-antiretroviral treatment issues. Most psychotropics are effective in the treatment of persons with HIV, but some, particularly the pa

APA, Harvard, Vancouver, ISO, and other styles

8

David, Elizabeth. Psychiatric Illness and Treatment in HIV Populations. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0037.

Full text

Abstract:

The interaction between HIV and mental illness is complex. For many individuals, the psychiatric condition is a preexisting one, predisposing to HIV infection through behavioral factors and risk environment. The risk factors for HIV are well established and involve blood/bodily fluid contact with infected individuals: unprotected sexual behaviors, needle sharing, multiple sexual partners, and fetal/natal exposure. Individuals with preexisting psychiatric illness often engage in risky behaviors with little thought or fear of consequences. This relates to increased emotional immaturity and impul

APA, Harvard, Vancouver, ISO, and other styles

9

Maggi, Julie Diana. The impact of attachment style and the physician-patient relationship on adherence to medication treatment in HIV disease. 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Breitbart, William, and Anna L. Dickerman. Fatigue and HIV. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0024.

Full text

Abstract:

Fatigue is commonly reported by persons with HIV and AIDS and is associated with impaired physical function, reduced quality of life, and suboptimal treatment adherence. Patients regard fatigue as an important condition to be addressed because it is disabling and distressing. In the past, fatigue was overlooked and undertreated by physicians, but clinicians caring for persons with HIV and AIDS have been giving more attention to symptom management and patients’ quality of life. Increased attention to symptom management in HIV and AIDS warrants familiarity with major issues in evaluation and tre

APA, Harvard, Vancouver, ISO, and other styles

11

Collins, Simon, Tim Horn, Loon Gangte, Emmanuel Trenado, and Vuyiseka Dubula. HIV Advocacy. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0010.

Full text

Abstract:

Community responses to the AIDS crisis have changed traditional approaches to medicine, healthcare, health systems, and research. Earlier approaches were rooted in widespread discrimination against key affected populations who were already socially marginalized. The background of community responses, first in the United States and then in other regions, each has a special history. This chapter provides an overview of historical community responses to HIV and is written by activists from the United States, India, South Africa and Western Europe. Examples of key projects include the role of peer

APA, Harvard, Vancouver, ISO, and other styles

12

Alfonso, César A., Eva Stern-Rodríguez, and Mary Ann Cohen. Suicide and HIV. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0025.

Full text

Abstract:

HIV is a risk factor for suicide. Even after developing effective treatments and reducing mortality of HIV in countries with access to care, psychological and medical multimorbidities continue to create distress. This chapter reviews the global epidemiology of suicide in persons with HIV and describes the known predisposing and protective factors, as well as the psychodynamics of suicide. Predisposing factors include course of illness, symptomatic multimorbidities, physical incapacity, history of trauma, past attempts, hopelessness, family suicide, bereavement, poor social support and family r

APA, Harvard, Vancouver, ISO, and other styles

13

David, Elizabeth, and John P. Casas. Substance Abuse in HIV Populations. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0030.

Full text

Abstract:

Mental illness and substance abuse are separate and additive risk factors for HIV infection. A comprehensive approach in the treatment of those with the dual diagnosis of mental illness and substance abuse is very important because these patients are inherently at a higher risk of contracting or transmitting sexually transmitted diseases, including HIV. Problems with adherence to medical treatment seem to be additive in this group. In addition, substance abuse is associated with a host of medical sequelae (liver disease, infection, diabetes, cardiovascular disease, and neurocognitive changes),

APA, Harvard, Vancouver, ISO, and other styles

14

Letendre, Scott, Jennifer Iudicello, Beau Ances, Thomas D. Marcotte, Serena Spudich, and Mary Ann Cohen. HIV-Associated Neurocognitive Disorders. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0016.

Full text

Abstract:

The human immunodeficiency virus (HIV) enters the central nervous system soon after infection; can infect glia and tissue macrophages in the brain; and can injure neurons, resulting in loss of dendrites. These and other processes underpin a syndrome of cognitive and motor impairment termed HIV-associated neurocognitive disorder (HAND). This chapter principally focuses on HAND, although delirium and other neurocognitive disorders are also discussed and should remain in the differential diagnosis of cognitive impairment in persons with HIV. A differential diagnosis of cognitive impairment in HIV

APA, Harvard, Vancouver, ISO, and other styles

15

Pahuja, Meera, Jessica S. Merlin, and Peter A. Selwyn. HIV/AIDS. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199656097.003.0151.

Full text

Abstract:

In less than two decades, AIDS has been transformed from a rapidly fatal, untreatable illness to a manageable chronic disease. Early in the AIDS epidemic, HIV care and palliative care were inseparable; over time, these two treatment paradigms diverged. In the developed world, and to a lesser but increasing extent in the developing world, decreasing mortality rates have resulted in growing numbers of HIV-infected patients living with the disease for many years. As this long-surviving population increases, the challenges of chronic disease management, an expanding range of co-morbidities, and a

APA, Harvard, Vancouver, ISO, and other styles

16

Mugavero, Michael J., and J. Michael Kilby. HIV/AIDS in the Fourth Decade. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0002.

Full text

Abstract:

This chapter discusses the maturing HIV/AIDS epidemic, now in its fourth decade, with global scale-up of antiretroviral therapy (ART) and reductions in the number of new HIV cases in many regions in the world. Advances in biomedical prevention with promising clinical trial findings for pre-exposure prophylaxis (PrEP) and microbicides provide a scientific foundation for the prevention of new infections in persons who are HIV uninfected and at risk. Landmark trials identifying the benefits of ART treatment as prevention (TasP) of new HIV infections and demonstrating the benefits of early ART ini

APA, Harvard, Vancouver, ISO, and other styles

17

Chaudoir, Stephenie R., and Jeffrey D. Fisher. Stigma and the “Social Epidemic” of HIV: Understanding Bidirectional Mechanisms of Risk and Resilience. Edited by Brenda Major, John F. Dovidio, and Bruce G. Link. Oxford University Press, 2017. http://dx.doi.org/10.1093/oxfordhb/9780190243470.013.28.

Full text

Abstract:

HIV/AIDS is one of the most devastating public health threats facing the modern world, and its eradication relies heavily on the performance of individual risk-reduction and treatment behaviors. In this chapter, a bidirectional lens is applied to consider how stigma systematically and synergistically constrains individual ability to perform behaviors critical to the effective prevention and treatment of HIV (e.g., sexual risk reduction and medication adherence), which ultimately compromises physical health. In addition to producing increased stigma, compromised physical health may further inhi

APA, Harvard, Vancouver, ISO, and other styles

18

Douaihy, Antoine, Melanie Grubisha, Maureen Lyon, and Mary Ann Cohen. Trauma and Posttraumatic Stress Disorder—The Special Role in HIV Transmission. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0017.

Full text

Abstract:

The prevalence of posttraumatic stress disorder (PTSD) in persons with HIV is higher than in the general population. Adults with HIV are likely to have experienced traumatic events that place them at risk for developing PTSD. Among women with HIV, PTSD may be more common than depression, suicidality, and substance use. The high prevalence of PTSD is related to increased exposure to traumatic experiences such as physical violence and sexual assault, including intimate partner violence and childhood sexual abuse. The co-occurrence of PTSD and HIV creates complex challenges for both the managemen

APA, Harvard, Vancouver, ISO, and other styles

19

Haskard-Zolnierek, Kelly B., Tricia A. Miller, and M. Robin DiMatteo. Promoting treatment adherence. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198736134.003.0037.

Full text

Abstract:

Empirical evidence demonstrates that quality healthcare outcomes depend greatly upon patients’ adherence to their recommended treatments. Patient adherence is a patient’s ability to follow his or her treatment recommendations given by a healthcare provider. Rates of adherence, however, can be as poor as 50% or less among patients with certain chronic diseases. For cancer patients, non-adherence can have serious consequences, including increased disease morbidity and mortality. Factors associated with non-adherence in cancer patients include treatment complexity, illness severity, patients’ bel

APA, Harvard, Vancouver, ISO, and other styles

20

Douaihy, Antoine, Matthew Conlon, and Maria Ferrara. Depressive and Bipolar Disorders. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0015.

Full text

Abstract:

Depressive disorders are highly prevalent among persons living with HIV/AIDS. Depressive disorders significantly negatively affects adherence to antiretroviral therapy and HIV viral suppression and is associated with poor quality of life and major impairment in overall functioning. This chapter reviews the prevalence, risk factors, assessment and diagnosis of depressive and bipolar disorders. It also examines the impact of depression on sexual behaviors, adherence to antiretroviral therapy, quality of life, and mortality. This chapter also includes a comprehensive discussion of treatment appro

APA, Harvard, Vancouver, ISO, and other styles

21

Cohen, Mary Ann, Harold Goforth, Joseph Lux, et al. Handbook of AIDS Psychiatry. Oxford University Press, 2010. http://dx.doi.org/10.1093/oso/9780195372571.001.0001.

Full text

Abstract:

The Handbook of AIDS Psychiatry is a practical guide for AIDS psychiatrists and other mental health professionals as well as for other clinicians who work with persons with HIV and AIDS and a companion book to the Comprehensive Textbook of AIDS Psychiatry (Cohen and Gorman, 2008). The Handbook provides insights into the dynamics of adherence to risk reduction and medical care in persons with HIV and AIDS as well as strategies to improve adherence using a biopsychosocial approach. Psychiatric disorders can accelerate the spread of the virus by creating barriers to risk reduction. Risky sexual b

APA, Harvard, Vancouver, ISO, and other styles

22

Soffer, Jocelyn, César A. Alfonso, John Grimaldi, and Jack M. Gorman. Psychotherapeutic Interventions. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0037.

Full text

Abstract:

Psychotherapeutic care for persons with HIV is an important component of overall treatment, helping people to cope and decreasing the psychological suffering that may be attendant when navigating the complex array of biopsychosocial stresses and challenges of living with HIV. A combination of psychotherapeutic and psychosocial interventions can effectively address psychological aspects of functioning and reduce psychiatric symptoms, as well as improve adherence to risk reduction and medical care. This chapter reviews several psychotherapeutic interventions, including supportive, psychodynamic,

APA, Harvard, Vancouver, ISO, and other styles

23

Al-Darraji, Haider A., and Frederick L. Altice. The Perfect Storm. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199374847.003.0008.

Full text

Abstract:

Globally, tuberculosis (TB) is a major cause of morbidity and mortality among people who use drugs (PWUD), particularly those co-infected with HIV. This chapter describes how TB is prevalent in several prison systems by virtue of the concentration of PWUD and people living with HIV. TB is further amplified within this system through overcrowding, poor ventilation, and delayed access to quality prevention and treatment services. In many countries, individuals cycling through prisons are inadequately screened and treated for TB, and affected individuals may have frequent treatment interruptions.

APA, Harvard, Vancouver, ISO, and other styles

24

Pandit, Neha Sheth, and Emily L. Heil. Principles of Applied Clinical Pharmacokinetics and Pharmacodynamics in Antiretroviral Therapy. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0018.

Full text

Abstract:

Systemic concentrations of antiretroviral drugs (ARVs) are influenced by the pharmacokinetic properties of absorption, distribution, metabolism, and excretion. Pharmacokinetics and local drug exposure can differ significantly within anatomical sanctuary sites compared with the systemic compartment. High variability in interpatient ARV concentrations is common, which makes population pharmacokinetics for ARVs very difficult to interpret. HIV replication is dynamic and requires combination antiretroviral therapy with multiple active agents in order to achieve durable virologic suppression. Direc

APA, Harvard, Vancouver, ISO, and other styles

25

Meyer, Jaimie P., and Frederick L. Altice. Transition to the community. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199360574.003.0047.

Full text

Abstract:

Re-incarceration of former prisoners is commonly associated with relapse to drug and alcohol use because of ineffective treatment of substance use disorders (SUDs) after release. High entry rates of people who use drugs (PWUDs) into prisons or jails results in the criminal justice system (CJS) bearing a disproportionate burden of the epidemic of people with SUDs. In contrast to 8% of U.S. adults in the general population, up to 65% of prisoners meet DSM-IV criteria for having a SUD and, depending on geographical location, 70% of HIV-infected prisoners meet criteria for opioid dependence. Thoug

APA, Harvard, Vancouver, ISO, and other styles

26

Helzlsouer, Kathy J., and Arti Patel Varanasi. Enhancing Fidelity to Cancer Treatment Guidelines. Edited by David A. Chambers, Wynne E. Norton, and Cynthia A. Vinson. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190647421.003.0019.

Full text

Abstract:

Cancer treatment has become increasingly complex with the rapid development of new therapies and treatment modalities. Guidelines for optimum cancer treatment are produced by several organizations, but ensuring that the patient receives the treatment requires both provider awareness and patient support to follow a complex treatment plan. An individual diagnosed with cancer must simultaneously come to terms with the diagnosis, make difficult shared decisions about treatment with his or her provider, and commence treatment in a matter of a few days or weeks. Ensuring optimum treatment is an incr

APA, Harvard, Vancouver, ISO, and other styles

27

Blashill, Aaron J., Janna R. Gordon, Matthew J. Mimiaga, and Steven A. Safren. HIV/AIDS and Depression. Edited by C. Steven Richards and Michael W. O'Hara. Oxford University Press, 2014. http://dx.doi.org/10.1093/oxfordhb/9780199797004.013.010.

Full text

Abstract:

Depression is highly prevalent among individuals living with HIV/AIDS. Depression not only affects quality of life for this population but also confers significant barriers to optimizing self-care behaviors, which are essential to medical care. Two of the most important HIV/AIDS care behaviors are medication adherence and safe sex practices; inadequacy in both can be associated with depression. Depression among those living with HIV/AIDS also is associated with substance abuse, which in turn predicts poor self-care. Importantly, there has recently been an emphasis on creating and testing integ

APA, Harvard, Vancouver, ISO, and other styles

28

Hull, Mark, and Steven C. Reynolds. HIV in the critically ill. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0291.

Full text

Abstract:

It has been over 30 years since the recognition of the acquired immune deficiency syndrome (AIDS), linked to infection with human immunodeficiency virus (HIV). Opportunistic infections arise in the setting of decreases in the CD4+ T-lymphocyte count. Advances in the safety, and effectiveness of combination antiretroviral therapy (cART) have led to substantial improvements in life-expectancy for individuals accessing successful therapy. As such individuals are likely to be admitted to the intensive care unit (ICU) for conditions un-related to HIV, although presentations due to opportunistic inf

APA, Harvard, Vancouver, ISO, and other styles

29

Douaihy, Antoine, Meredith Spada, Nicole Bates, Julia Macedo, and Jack M. Gorman. Anxiety Disorders. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0018.

Full text

Abstract:

HIV practitioners are increasingly confronted with complex co-occurring medical and psychiatric disorders among their patients. Depressive and anxiety disorders are among the most commonly diagnosed in HIV-infected individuals and can complicate the overall management of HIV illness. Anxiety may be experienced as a symptom, as a manifestation of an anxiety disorder, as a consequence of HIV-associated or other illness, or as a result of one of its treatments. It can occur at any stage, from the realization of being at risk, to the anxiety about a possible symptom, to the time of HIV testing and

APA, Harvard, Vancouver, ISO, and other styles

30

Bennell, Kim L., Ans Van Ginckel, Fiona Dobson, and Rana S. Hinman. Exercise for the person with osteoarthritis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199668847.003.0022.

Full text

Abstract:

Because of its beneficial effects on pain and physical dysfunction commonly reported by afflicted individuals, all clinical guidelines of osteoarthritis (OA) advocate exercise therapy as a vital component of conservative management strategies. Although the optimal exercise modalities in terms of dosage, exercise type, or delivery mode are not yet known, clinical benefits can be achieved with a wide range of exercise types. While treatment effect sizes may be considered small to moderate, they are similar to those of common analgesic drugs or oral non-steroidal anti-inflammatories but seem to e

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!